Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data.

Chiara Rapisarda

dblp:425/4319 · DBLP profile ↗
← Back
1ranked-venue papers
0as first author
1since 2021 · last 2025
—ORCID · unresolved

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 4 heaviest of 4, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › structural bioinformatics
cryo-EM map analysis
0.912025
Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025
Bioinformatics and computational biology
structural bioinformatics
0.912025
Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025
Bioinformatics and computational biology
drug discovery
0.312025
Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025
Bioinformatics and computational biology › protein design
therapeutic antibody design
0.312025
Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025

Methods — techniques the papers use, named apart from their topics

machine learning · 0.9
YearPublicationVenuePosition
2025 Finding antibodies in cryo-EM maps with <tt>CrAI</tt>
abstract
MOTIVATION: Therapeutic antibodies have emerged as a prominent class of new drugs due to their high specificity and their ability to bind to several protein targets. Once an initial antibody has been identified, its design and characteristics are refined using structural information, when it is available. Cryo-EM is currently the most effective method to obtain 3D structures. It relies on well-established methods to process raw data into a 3D map, which may, however, be noisy and contain artifacts. To fully interpret these maps the number, position, and structure of antibodies and other proteins present must be determined. Unfortunately, existing automated methods addressing this step have limited accuracy, require additional inputs and high-resolution maps, and exhibit long running times. RESULTS: We propose the first fully automatic and efficient method dedicated to finding antibodies in cryo-EM maps: CrAI. This machine learning approach leverages the conserved structure of antibodies and a dedicated novel database that we built to solve this problem. Running a prediction takes only a few seconds, instead of hours, and requires nothing but the cryo-EM map, seamlessly integrating within automated analysis pipelines. Our method can find the location and pose of both Fabs and VHHs at resolutions up to 10 Å and is significantly more reliable than existing approaches. AVAILABILITY AND IMPLEMENTATION: We make our method available both in open source github.com/Sanofi-Public/crai and as a ChimeraX bundle (crai).
Vincent Mallet, Chiara Rapisarda, Hervé Minoux, Maks Ovsjanikov
Bioinform.2